Aquestive Therapeutics, Inc. Shares Outstanding (Cover Page)
Aquestive Therapeutics, Inc. (AQST) had Shares Outstanding (Cover Page) of 125.51 million shares as of 2026-08-07, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-11
- 2026-08-07: Entity Common Stock, Shares Outstanding 125.51M shares.
- 2026-05-11: Entity Common Stock, Shares Outstanding 125.45M shares.
- 2026-03-02: Entity Common Stock, Shares Outstanding 122.05M shares.
- 2025-11-03: Entity Common Stock, Shares Outstanding 122.00M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-07 | 125.51M shares 10-Q · filed 2026-08-11 |
| 2026-05-11 | 125.45M shares 10-Q · filed 2026-05-13 |
| 2026-03-02 | 122.05M shares 10-K · filed 2026-03-04 |
| 2025-11-03 | 122.00M shares 10-Q · filed 2025-11-05 |
| 2025-08-07 | 99.72M shares 10-Q · filed 2025-08-11 |
| 2025-05-08 | 99.33M shares 10-Q · filed 2025-05-12 |
| 2025-03-03 | 98.87M shares 10-K · filed 2025-03-05 |
| 2024-11-01 | 91.18M shares 10-Q · filed 2024-11-04 |
| 2024-08-02 | 91.06M shares 10-Q · filed 2024-08-06 |
| 2024-05-03 | 91.04M shares 10-Q · filed 2024-05-07 |
| 2024-03-01 | 73.30M shares 10-K · filed 2024-03-05 |
| 2023-11-03 | 66.77M shares 10-Q · filed 2023-11-06 |
| 2023-08-04 | 61.73B shares 10-Q · filed 2023-08-07 |
| 2023-04-26 | 55.92M shares 10-Q · filed 2023-05-02 |
| 2023-03-01 | 55.87M shares 10-K · filed 2023-03-31 |
| 2022-10-24 | 54.16M shares 10-Q · filed 2022-11-01 |
| 2022-07-25 | 53.35M shares 10-Q · filed 2022-08-02 |
| 2022-04-25 | 41.91M shares 10-Q · filed 2022-05-04 |
| 2022-03-01 | 41.47M shares 10-K · filed 2022-03-08 |
| 2021-10-25 | 40.16M shares 10-Q · filed 2021-11-02 |
| 2021-07-26 | 38.89M shares 10-Q · filed 2021-08-03 |
| 2021-04-30 | 36.59M shares 10-Q · filed 2021-05-04 |
| 2021-03-05 | 36.21M shares 10-K · filed 2021-03-09 |
| 2020-11-02 | 33.62M shares 10-Q · filed 2020-11-04 |
| 2020-07-31 | 33.62M shares 10-Q · filed 2020-08-04 |
| 2020-05-01 | 33.58M shares 10-Q · filed 2020-05-05 |
| 2020-03-06 | 33.58M shares 10-K · filed 2020-03-11 |
| 2019-11-01 | 25.04M shares 10-Q · filed 2019-11-05 |
| 2019-08-02 | 25.03M shares 10-Q · filed 2019-08-06 |
| 2019-05-03 | 24.98M shares 10-Q · filed 2019-05-08 |
| 2019-03-08 | 24.98M shares 10-K · filed 2019-03-14 |
| 2018-10-31 | 24.94M shares 10-Q · filed 2018-11-06 |
| 2018-08-31 | 24.94M shares 10-Q · filed 2018-09-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |